Literature DB >> 9677459

A case of pleomorphic adenoma of the lung with multiple distant metastases--observations on its oncogene and tumor suppressor gene expression.

E Takeuchi1, E Shimizu, N Sano, T Yamaguchi, H Yanagawa, S Sone.   

Abstract

Pleomorphic adenoma of the lung is a rare neoplasm. Here we describe the first report on oncogenes and tumor suppressor genes in metastasizing pleomorphic adenoma of the lung. A 48-year-old Japanese woman presented with metastasizing pleomorphic adenoma in which both the primary lung tumor and metastatic lesions were composed of benign pleomorphic structures. The mechanism of the metastatic potential was examined by analyzing known oncogenes and tumor suppressor genes by DNA blot analysis and immunohistochemistry. No rearrangements amplifications or overexpressions of oncogenes, bcl-2, c-erbB-2, c-myc, L-myc, N-myc, Ha-ras and Ki-ras were found. In addition, immunohistochemical studies showed no aberrance in expressions of the tumor suppressor gene products, RB, p16 and p53 in the tumor. Some unknown mechanism(s) seems to be responsible for the aggressiveness of this metastasizing pleomorphic adenoma. This mechanism must be elucidated by studies on further case of this rare tumor.

Entities:  

Mesh:

Year:  1998        PMID: 9677459

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Pleural recurrence after surgery for pleomorphic adenoma arising from peripheral lung: computed tomography-guided percutaneous needle biopsy as a possible mechanism of local failure.

Authors:  Toshiteru Tokunaga; Hidenori Kunou; Daisuke Ishida; Takashi Kanou; Jiro Okami; Yasuhiko Tomita; Masahiko Higashiyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-21

2.  A case of initially metastasizing pleomorphic adenoma of parotid gland.

Authors:  Sungchul Ko; Kye Hoon Park; Ji-Hye Lee; Ki Nam Park
Journal:  Rare Tumors       Date:  2022-10-03

3.  Pulmonary pleomorphic adenoma: report of a rare case.

Authors:  Heung-Yong Jin; Tae-Sun Park
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 3.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.